Billionaire investor Daniel Loeb's hedge fund Third Point is building a stake in Kenvue , sources familiar with the matter ...

Kenvue (NYSE:KVUE), the consumer care spinoff of Johnson & Johnson’s (JNJ), traded higher on Friday after The Financial Times ...

CNBC's Andrew Ross Sorkin discuss the key takeaways from his conversation with legendary activist investor Dan Loeb.

Resolving uncertainty surrounding President Trump’s tariffs and backing away from installing a new chair of the Federal ...

Dan Loeb’s Third Point Capital has built a stake in Tylenol and Neutrogena maker Kenvue (KVUE), people familiar with the matter told Financial Times’ Oliver Barnes and Amelia Pollard.

The MTD performance figures are calculated by reference to the previous estimated month end NAV or, if published, the previous month end confirmed NAV including the effect of any dividends or shares ...

NEW YORK (Reuters) -Billionaire investor Daniel Loeb's hedge fund Third Point is building a stake in Kenvue, sources familiar with the matter said on Friday, as some investors are pushing for ...

The details about the size of Third Point’s stake, as well as the level of the firm’s engagement with Kenvue (NYSE:KVUE), were not immediately clear. Summit, New Jersey-based KVUE refused to ...

Third Point Investors Ltd - Weekly Estimate Net Asset Value - April 2025 PR Newswire LONDON, United Kingdom, April 25 Third Point Investors Limited (the "Company") (a closed-ended investment ...

News of Third Point's investment in the $44 billion Summit, New Jersey-headquartered maker of Band-Aids and Tylenol helped push its share price up more than 2% in late afternoon trading on Friday ...